Safety Study of GC1118 (Recombinant Human Anti-EGFR Antibody) in Patients With Advanced Solid Cancer
Clinical trial NCT02352571 · UNKNOWN
Trial details
- NCT number
- NCT02352571
- Sponsor
- Green Cross Corporation
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-01
- Primary completion
- 2016-12-01
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.